PolyNovo Limited (ASX:PNV), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the ASX over the last few months. Shareholders may appreciate the ...
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Meclizine (PNV) is an antihistamine, prescribed ...
The average one-year price target for PolyNovo (ASX:PNV) has been revised to 1.80 / share. This is an decrease of 12.02% from the prior estimate of 2.05 dated November 26, 2023. The price target is an ...
Fintel reports that on August 5, 2024, BELL POTTER SECURITIES downgraded their outlook for PolyNovo (ASX:PNV) from Buy to Hold. As of August 6, 2024, the average one-year price target for PolyNovo is ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results